Andrew Obenshain
CIK 1839697 · President and CEO · last filed 2025-06-03
Andrew Obenshain is a President and CEO who has filed 28 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for BLUE, was dated Jun 3, 2025. Across all open-market trades the lifetime net is −$354.1K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
28
-$354.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| bluebird bio, Inc. (BLUE) Delisted | President and CEO | 9,300 | $4.97 | $46.2K | -$354.1K | 28 | 2025-06-03 |
Recent Filings
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-03 | bluebird bio, Inc. (BLUE) Delisted | Mixed | −18,327 | $0 | EDGAR |
| 2025-03-05 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −921 | -$3.6K | EDGAR |
| 2025-02-12 | bluebird bio, Inc. (BLUE) Delisted | Grant (A) | +763 | $0 | EDGAR |
| 2025-02-05 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −86 | -$636 | EDGAR |
| 2025-01-08 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −140 | -$1.3K | EDGAR |
| 2024-12-12 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −971 | -$405 | EDGAR |
| 2024-10-02 | bluebird bio, Inc. (BLUE) Delisted | Mixed | +95,220 | -$18.3K | EDGAR |
| 2024-03-05 | bluebird bio, Inc. (BLUE) Delisted | Mixed | −6,095 | -$9.3K | EDGAR |
| 2024-02-06 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −1,879 | -$1.7K | EDGAR |
| 2024-01-09 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −3,162 | -$4.5K | EDGAR |